Drug Trial Radar · NCT01993940
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
Last checked: Nov 20, 2026Latest source record: May 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
553
Actual
Start
Nov 4, 2013
Primary completion
Jun 9, 2015
Study completion Jun 9, 2015
Sponsor
- Lead sponsor
- ShionogiIndustry
- Sponsor type
- Industry
- First posted
- Nov 25, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.
Conditions
- Opioid-induced Constipation
Interventions
NaldemedineDrug
Naldemedine 0.2 mg tablet taken orally once a day
PlaceboDrug
Placebo tablet taken orally once a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With a Spontaneous Bowel Movement (SBM) ResponseTime frame: 12-week treatment period
Locations
49 sites in 1 country. Site status is shown where the registry gives one.
Shionogi Research Site
Birmingham, Alabama
Shionogi Research Site
Homewood, Alabama
Shionogi Research Site
Goodyear, Arizona
Shionogi Research Site
Little Rock, Arkansas
Shionogi Research Site
Anaheim, California
Shionogi Research Site
Buena Park, California
Shionogi Research Site
Corona, California
Shionogi Research Site
Gold River, California
Shionogi Research Site
Los Angeles, California
Shionogi Research Site
Modesto, California
Shionogi Research Site
Pasadena, California
Shionogi Research Site
Coral Gables, Florida
Shionogi Research Site
Hialeah, Florida
Shionogi Research Site
Jacksonville, Florida
Shionogi Research Site
Miami, Florida
Shionogi Research Site
Miami Beach, Florida
Shionogi Research Site
Plantation, Florida
Shionogi Research Site
Columbus, Georgia
Shionogi Research Site
Evansville, Indiana
Shionogi Research Site
Indianapolis, Indiana
Shionogi Research Site
West Des Moines, Iowa
Shionogi Research Site
Edgewood, Kentucky
Shionogi Research Site
Crowley, Louisiana
Shionogi Research Site
Kalamazoo, Michigan
Shionogi Research Site
Traverse City, Michigan
Shionogi Research Site
Butte, Montana
Shionogi Research Site
Omaha, Nebraska
Shionogi Research Site
Las Vegas, Nevada
Shionogi Research Site
Omaha, Nevada
Shionogi Research Site
Albuquerque, New Mexico
Shionogi Research Site
Hopewell Junction, New York
Shionogi Research Site
Mooresville, North Carolina
Shionogi Research Site
Winston-Salem, North Carolina
Shionogi Research Site
Dayton, Ohio
Shionogi Research Site
Marion, Ohio
Shionogi Research Site
Media, Pennsylvania
Shionogi Research Site
Spartanburg, South Carolina
Shionogi Research Site
Knoxville, Tennessee
Shionogi Research Site
Tullahoma, Tennessee
Shionogi Research Site
Channelview, Texas
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.